Factors and preventive strategies for perioperative euglycemic diabetic ketoacidosis in patients with type 2 diabetes receiving sodium-glucose cotransporter 2 inhibitors: a retrospective study
Our findings suggest that preoperative SGLT2i discontinuation for at least 3 days could prevent perioperative euDKA development and that preoperative insulin and glucose infusion could reduce the risk of developing euDKA, even in patients who cannot discontinue SGLT2is at least 3 days preoperatively.
Authors
- Kenji Ikemura (ORCID: https://orcid.org/0000-0003-1870-9571)
- Miho Takemura (ORCID: https://orcid.org/0000-0002-7170-6938)
- Masahiro Okuda (ORCID: https://orcid.org/0000-0001-5655-457X)
Institutions
- Osaka University Hospital (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- Journal of Pharmaceutical Health Care and Sciences
- Published
- 2025-08-25
- DOI
- https://doi.org/10.1186/s40780-025-00487-6
- Citations
- 1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.29